AT370624B - Verfahren zur herstellung von dosiereinheiten mit einem gehalt an acetylsalicylsaeure und alkalisch reagierenden verbindungen - Google Patents

Verfahren zur herstellung von dosiereinheiten mit einem gehalt an acetylsalicylsaeure und alkalisch reagierenden verbindungen

Info

Publication number
AT370624B
AT370624B AT0355281A AT355281A AT370624B AT 370624 B AT370624 B AT 370624B AT 0355281 A AT0355281 A AT 0355281A AT 355281 A AT355281 A AT 355281A AT 370624 B AT370624 B AT 370624B
Authority
AT
Austria
Prior art keywords
reactive compounds
units containing
dosing units
alkaline reactive
producing
Prior art date
Application number
AT0355281A
Other languages
English (en)
Other versions
ATA355281A (de
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/179,191 external-priority patent/US4294819A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of ATA355281A publication Critical patent/ATA355281A/de
Application granted granted Critical
Publication of AT370624B publication Critical patent/AT370624B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0355281A 1980-08-18 1981-08-13 Verfahren zur herstellung von dosiereinheiten mit einem gehalt an acetylsalicylsaeure und alkalisch reagierenden verbindungen AT370624B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/179,191 US4294819A (en) 1980-08-18 1980-08-18 Alkaline analgesic capsule
US06/273,015 US4339428A (en) 1980-08-18 1981-06-18 Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component

Publications (2)

Publication Number Publication Date
ATA355281A ATA355281A (de) 1982-09-15
AT370624B true AT370624B (de) 1983-04-25

Family

ID=26875096

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0355281A AT370624B (de) 1980-08-18 1981-08-13 Verfahren zur herstellung von dosiereinheiten mit einem gehalt an acetylsalicylsaeure und alkalisch reagierenden verbindungen

Country Status (25)

Country Link
US (1) US4339428A (de)
AT (1) AT370624B (de)
AU (1) AU549488B2 (de)
CA (1) CA1156554A (de)
CH (1) CH646331A5 (de)
DD (1) DD201643A5 (de)
DE (1) DE3132518A1 (de)
DK (1) DK159374C (de)
ES (1) ES504797A0 (de)
FI (1) FI77371C (de)
FR (1) FR2488508A1 (de)
GB (1) GB2082456B (de)
GR (1) GR74618B (de)
HU (1) HU187354B (de)
IE (1) IE51501B1 (de)
IL (1) IL63577A0 (de)
IT (1) IT1143221B (de)
LU (1) LU83559A1 (de)
NL (1) NL8103804A (de)
NO (1) NO155476C (de)
NZ (1) NZ198045A (de)
OA (1) OA06883A (de)
PT (1) PT73530B (de)
SE (1) SE451667B (de)
ZW (1) ZW19781A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
US4507276A (en) * 1982-08-20 1985-03-26 Bristol-Myers Company Analgesic capsule
US4578075A (en) * 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4681583A (en) * 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4773907A (en) * 1982-12-20 1988-09-27 Alza Corporation Primary delivery system comprising secondary dosage form
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
DE3572440D1 (en) * 1984-06-19 1989-09-28 Basf Ag Gastro-resistant cylindrical pancreatine-microtablets
US4867984A (en) * 1984-11-06 1989-09-19 Nagin K. Patel Drug in bead form and process for preparing same
US4728512A (en) * 1985-05-06 1988-03-01 American Home Products Corporation Formulations providing three distinct releases
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
DE3600084A1 (de) * 1986-01-03 1987-07-09 Scherer Gmbh R P Formkoerper sowie verfahren und vorrichtung zur herstellung eines solchen formkoerpers
US4904476A (en) * 1986-03-04 1990-02-27 American Home Products Corporation Formulations providing three distinct releases
US4794001A (en) * 1986-03-04 1988-12-27 American Home Products Corporation Formulations providing three distinct releases
EP0320550A1 (de) * 1987-12-18 1989-06-21 Bristol-Myers Company NSAID-Zusammensetzungen mit Gehalt an H1-Blockern, H2-Blockern, beta-adrenergischen Agonisten oder Mischungen hiervon und an einem Alkalinisierungsmittel
US5071842A (en) * 1988-10-14 1991-12-10 Bristol-Myers Squibb Company Aspirin-containing composition including diphenhydramine and an alkalizing agent to reduce gastrointestinal injury potential
US4980175A (en) * 1989-01-03 1990-12-25 Leonard Chavkin Liquid orally administrable compositions based on edible oils
JP3230814B2 (ja) * 1989-09-15 2001-11-19 シーマ・ラブス、インコーポレイション 炭酸マグネシウムおよびオイルタブレット形成助剤
DE4102629A1 (de) * 1991-01-30 1992-08-06 Bayer Ag Pharmazeutischer kaugummi mit acetylsalicylsaeure
HU9202318D0 (en) * 1991-07-22 1992-10-28 Bristol Myers Squibb Co Method for preparing medical preparatives containing didesoxi-purine nucleoside
US5834479A (en) * 1993-03-05 1998-11-10 Mayer; David J. Method and composition for alleviating pain
US5391230A (en) * 1993-07-07 1995-02-21 Eastman Kodak Company Apparatus for holding solid compact medicaments during processing
CA2197463A1 (en) * 1994-09-02 1996-03-14 David J. Mayer Composition alleviating pain, containing a non-narcotic analgesic and an analgesia enhancer
DE19603402A1 (de) * 1995-02-24 1996-08-29 Basf Ag Weichgelatinekapseln
US6274592B1 (en) 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
DE19849848A1 (de) * 1998-10-29 2000-05-04 Lohmann Therapie Syst Lts Oral applizierbare, mit Flüssigkeit spontan zerfallende therapeutische Darreichungsform und Verfahren zu ihrer Herstellung
US6428809B1 (en) * 1999-08-18 2002-08-06 Microdose Technologies, Inc. Metering and packaging of controlled release medication
US6511494B1 (en) 2000-11-17 2003-01-28 Embro Corporation Vein harvesting system and method
US6887492B2 (en) * 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
US6576665B2 (en) * 2001-04-03 2003-06-10 Braintree Laboratories, Inc. Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption
US20070087048A1 (en) * 2001-05-31 2007-04-19 Abrams Andrew L Oral dosage combination pharmaceutical packaging
WO2003055468A1 (en) * 2001-12-21 2003-07-10 Shire Laboratories Inc. Oral capsule formulation with increased physical stability
TW200510002A (en) * 2003-06-06 2005-03-16 Takeda Chemical Industries Ltd Solid pharmaceutical preparation
US7198653B2 (en) * 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US20050282756A1 (en) * 2004-06-18 2005-12-22 Mehta Nozer M Oral delivery of peptide pharmaceutical compositions
US20060222705A1 (en) * 2005-03-31 2006-10-05 Flanner Henry H Pharmaceutical tablet and apparatus and method for making
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
DE102008025798C5 (de) 2008-05-29 2015-08-06 Guangdong Fushan Glass Machinery Co., Ltd. Verfahren zum Betreiben eines Rollenofens
WO2011008546A2 (en) * 2009-06-29 2011-01-20 Capricorn Pharma, Inc. Solid and semi-solid dosage forms and systems and methods for forming and packaging thereof
EP2521584B1 (de) 2010-01-05 2018-10-17 MicroDose Therapeutx, Inc. Inhalationsvorrichtung
US20130143867A1 (en) * 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
IL230419A0 (en) 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses
EP3003297A4 (de) 2013-06-05 2017-04-19 Synchroneuron Inc. Acamprosat-formulierungen, verfahren zur verwendung davon und kombinationen damit
WO2017062954A1 (en) 2015-10-09 2017-04-13 Binutra Incorporated Capsule with internal diaphragm for improved bioavailability

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA593581A (en) * 1960-03-01 W. E. Harrisson Joseph Analgesic product
FR808949A (fr) * 1936-07-31 1937-02-18 Perfectionnements à la préparation des cachets pharmaceutiques
US2224256A (en) * 1938-08-05 1940-12-10 Baker Chem Co J T Pharmaceutical preparation
GB613080A (en) * 1946-05-17 1948-11-22 Myer Coplans Improvements in the preparation of stable medicinal salts of acetylsalicylic acid
US2698332A (en) * 1951-04-20 1954-12-28 Reheis Company Inc Aspirin derivative and method of making
GB754364A (en) * 1953-10-09 1956-08-08 Drug Houses Of Australia Ltd Improvements in medicinal preparations containing acetylsalicylic acid
US2918485A (en) * 1955-09-21 1959-12-22 Keystone Chemurgic Corp Dihydroxy aluminum salicylates
US2889248A (en) * 1955-12-13 1959-06-02 Drug Processors Inc Therapeutic composition containing aluminum proteinate
US2801951A (en) * 1956-01-09 1957-08-06 Sterling Drug Inc Stabilized analgesic compositions
GB827529A (en) * 1956-02-27 1960-02-03 Macleans Ltd Improvements in or relating to the manufacture of tablets
US2888382A (en) * 1957-10-28 1959-05-26 Upjohn Co Therapeutic composition and process
BE585778A (de) * 1958-04-18
US3019169A (en) * 1958-06-23 1962-01-30 Sterling Drug Inc Salicylate dry shell coating of dry 4-aminoquinoline core, and dry-compressing tablet-making process
US3323992A (en) * 1960-09-29 1967-06-06 Keystone Chemurgic Corp Antacid composition of hydrated magnesium aluminate containing bound sulfate
US3341416A (en) * 1963-12-11 1967-09-12 Ncr Co Encapsulation of aspirin in ethylcellulose and its product
GB1204580A (en) 1968-10-05 1970-09-09 Aspro Nicholas Ltd Pharmaceutical dosage forms
US3608064A (en) * 1969-10-07 1971-09-21 Anthony H Lamb Milk-buffered aspirin
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule

Also Published As

Publication number Publication date
FI812505L (fi) 1982-02-19
GB2082456B (en) 1984-10-24
NL8103804A (nl) 1982-03-16
NO155476B (no) 1986-12-29
ZW19781A1 (en) 1982-06-16
IT1143221B (it) 1986-10-22
NO812678L (no) 1982-02-19
US4339428A (en) 1982-07-13
ATA355281A (de) 1982-09-15
SE8104881L (sv) 1982-02-19
IL63577A0 (en) 1981-11-30
OA06883A (fr) 1983-04-30
FR2488508A1 (fr) 1982-02-19
PT73530A (en) 1981-09-01
ES8301622A1 (es) 1982-12-16
FR2488508B1 (de) 1985-05-10
GB2082456A (en) 1982-03-10
NZ198045A (en) 1985-01-31
FI77371B (fi) 1988-11-30
NO155476C (no) 1987-04-08
CH646331A5 (de) 1984-11-30
PT73530B (en) 1983-10-20
AU549488B2 (en) 1986-01-30
GR74618B (de) 1984-06-29
DK159374C (da) 1991-07-01
ES504797A0 (es) 1982-12-16
IE51501B1 (en) 1987-01-07
SE451667B (sv) 1987-10-26
FI77371C (fi) 1989-03-10
DE3132518A1 (de) 1982-05-27
HU187354B (en) 1985-12-28
AU7368281A (en) 1982-02-25
LU83559A1 (fr) 1982-04-14
DK159374B (da) 1990-10-08
IE811881L (en) 1982-02-18
DD201643A5 (de) 1983-08-03
IT8149078A0 (it) 1981-08-10
CA1156554A (en) 1983-11-08
DK362781A (da) 1982-02-19

Similar Documents

Publication Publication Date Title
AT370624B (de) Verfahren zur herstellung von dosiereinheiten mit einem gehalt an acetylsalicylsaeure und alkalisch reagierenden verbindungen
AT375652B (de) Verfahren zur herstellung von arylaliphatischen polyisozyanuraten
AT375302B (de) Verfahren zur herstellung von kunststoffbeschichteten fluessigkeitsverpackungen
AT374827B (de) Verfahren zur herstellung von cholesterase
AT372382B (de) Verfahren zur herstellung von neuen oxiranylisocyanursaeureverbindungen
AT380240B (de) Verfahren zur herstellung von neuen heterocyclischen verbindungen
AT373602B (de) Verfahren zur herstellung von phosphorkohlenstoff-stickstoff-bindung enthaltenden verbindungen
AT367436B (de) Verfahren zur herstellung von copolymerisaten
PT69377A (de) Verfahren zur herstellung von dilignolen und dilignolahnlichen verbindungen
AT377253B (de) Verfahren zur herstellung von harnstoff
AT370058B (de) Verfahren zur herstellung von ammoniak
AT371469B (de) Verfahren zur herstellung von neuen penamcarbonsaeure-derivaten
AT387770B (de) Verbessertes verfahren zur herstellung von trichlorisocyanursaeure
AT380686B (de) Verfahren zur herstellung von buspiron
AT370281B (de) Verfahren zur herstellung von zur teearomatisierung dienenden granulaten
AT375915B (de) Verfahren zur herstellung von carbonsaeureamiden
AT375328B (de) Verfahren zur herstellung von sintermagnesia
AT375636B (de) Verfahren zur herstellung von 3-acylazopropionsaeureestern
PT72283B (de) Verfahren zur herstellung von korkgranulatplatten
AT374793B (de) Verfahren zur herstellung von 1-methyl-5(p-toluoyl)-pyrrol-2-essigsaeure
ATA110780A (de) Verfahren zur herstellung von o-trimethylsilyl- -cellulosen
ATA231982A (de) Verfahren zur herstellung von neuen verbindungen
AT374794B (de) Verfahren zur herstellung von 1-methyl-5(p-toluoyl)-pyrrol-2-essigsaeure
ATA254780A (de) Verfahren zur herstellung von isocyansaeureestern
ATA230781A (de) Verfahren zur herstellung von carbonsaeureestern

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee